Recent articles

Amoxicillin is the drug of first choice to treat community-acquired pneumonia (CAP) in children below 5 years of age. There is, however, no consensus about the dosage or the duration of the course ...

A previous Ge-Bu article concluded that too little research had been published to answer the question whether vaccination against human papillomavirus (HPV) protects against cervical carcinoma. De ...

Since the beginning of 2021, two mRNA vaccines and two vector vaccines against SARS-CoV-2 have been available in the Netherlands, and a large proportion of the population have now been vaccinated. ...

A recently published Cochrane systematic review and meta-analysis examined the efficacy and adverse effects of esketamine (and other drugs) to treat severe (or very severe) depression. Treatment o ...

Treatment for patients with type 2 diabetes mellitus and chronic kidney or cardiovascular disease has to focus on blocking the renin-angiotensin-aldosterone system (RAAS). In specific cases, the ( ...

Ondansetron is a serotonin receptor antagonist which has been authorised for use as an anti-emetic in the context of chemotherapy (from an age of 6 months) and radiotherapy (in adults). It has als ...

Recent years have seen major progress in the treatment of chronic hepatitis C. New direct-acting antiviral agents (DAAs) have become available in the Netherlands from the end of 2014. Combinations ...

The discovery of the role of ‘calcitonin gene-related peptide’ (CGRP) in the development of migraine enabled new drugs for the treatment of this condition to be developed. The monoclonal CGRP anta ...